59 results
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
which bring the reputation of the PLC or any Group Company into material disrepute; (v) any act or omission by Executive aiding or abetting a competitor
8-K
EX-10.3
aegamc p6
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.4
7ij1 noz22k
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
8-K
EX-10.2
uud5qg
1 Jun 23
Adaptimmune Announces Completion of Strategic Combination with TCR² Therapeutics Creating a Preeminent Solid Tumor Cell Therapy Company
4:09pm
424B3
g3qnkvkkpkei
20 Apr 23
Prospectus supplement
4:32pm
S-4/A
8sbh6m0bcrz51xwg4h
18 Apr 23
Registration of securities issued in business combination transactions (amended)
4:01pm
S-4
kw1y 4szwwnpx5o8jf5c
5 Apr 23
Registration of securities issued in business combination transactions
4:40pm
8-K
EX-10.01
1gg1akwomxphuv7e
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am